United Therapeutics Corporation · NASDAQ:UTHR

Mahon Paul A sold 8,300 United Therapeutics Corporation shares (Form 4)

Traded Jul 2, 2026 · Filed Jul 2, 2026

On Jul 2, 2026, Mahon Paul A (EVP & GENERAL COUNSEL) sold 8,300 United Therapeutics Corporation shares at an average US$552.57 for US$4.59M under a trading plan, leaving 45,172 shares. Filed Jul 2, 2026 (Form 4).

Sold
8,300 shares
Price
US$552.57 average (US$548.00 to US$556.36)
Value
US$4.59M
Holding after
45,172 shares
Trading plan
Yes (Made under a plan set in advance)
Role
EVP & GENERAL COUNSEL

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 2, 2026Common StockOption exercise8,300US$146.0353,472Direct
Jul 2, 2026Common StockSale658US$548.0052,814Direct
Jul 2, 2026Common StockSale258US$548.7352,556Direct
Jul 2, 2026Common StockSale384US$550.0252,172Direct
Jul 2, 2026Common StockSale1,467US$551.3050,705Direct
Jul 2, 2026Common StockSale1,818US$552.6148,887Direct
Jul 2, 2026Common StockSale2,201US$553.5246,686Direct
Jul 2, 2026Common StockSale299US$554.4546,387Direct
Jul 2, 2026Common StockSale990US$555.8345,397Direct
Jul 2, 2026Common StockSale225US$556.3645,172Direct

Source

View original at SEC

Related